Cargando…
Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc
c-Myc is a key oncogenic transcription factor that participates in tumor pathogenesis. In this study, we found that levels of c-Myc mRNA and protein were higher in early ovarian cancer tissues than normal ovary samples. Increased c-Myc levels correlated positively with clinical stage I (Ia+b/Ic) in...
Autores principales: | Ning, Ying-Xia, Luo, Xin, Xu, Meng, Feng, Xin, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650382/ https://www.ncbi.nlm.nih.gov/pubmed/29088827 http://dx.doi.org/10.18632/oncotarget.20413 |
Ejemplares similares
-
Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma
por: Wang, Zifeng, et al.
Publicado: (2016) -
Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy
por: Dai, Xin, et al.
Publicado: (2015) -
7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1
por: NING, YING-XIA, et al.
Publicado: (2014) -
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB
por: Solomon, Leigh A, et al.
Publicado: (2008) -
LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
por: Miao, Jin-Tian, et al.
Publicado: (2019)